Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/30964837http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/30964837http://www.w3.org/2000/01/rdf-schema#comment"

Background

The development of liver transplantation (LT) is increasingly being limited by the unavailability of liver grafts. Unique regenerative capacity of liver in response to injuries makes living-donor liver transplantation (LDLT) a feasible strategy to meet clinical demands. Serine hydroxymethyl-transferase 2 (SHMT2) serves as the key enzyme in the biosynthesis of glycine. Glycine affects the activity of mammalian target of rapamycin (mTOR), which is important for cellular growth and proliferation. In this study, the effects of SHMT2 on mouse liver regeneration were investigated using a classical partial hepatectomy (PH) model.

Methods

In vivo, PH was performed on mice with or without knockdown of SHMT2. In vitro, SHMT2 was overexpressed in primary hepatocytes, which were cultured in customized Dulbecco's modified eagle media and LY294002 (an Akt inhibitor). Relevant indexes of liver regeneration, cell proliferation, and Akt/mTOR signal pathways were analyzed.

Results

After PH, the expression levels of SHMT2 fluctuated with time and knockdown of SHMT2 in vivo lowered the regenerative ability of liver, with reduced glycine levels compared to the scramble group. In addition, overexpression of SHMT2 in hepatocytes boosted glycine production while enhancing Akt/mTOR pathway activity. These results were validated by the application of LY294002 in vitro.

Conclusions

SHMT2 can contribute to liver regeneration after PH, and this is likely related to the activation of Akt/mTOR signaling pathway by its metabolic product, glycine, in hepatocytes. These results might have therapeutic implications for the prognosis of patients undergoing hepatic resection or transplantation."xsd:string
http://purl.uniprot.org/citations/30964837http://purl.org/dc/terms/identifier"doi:10.1097/tp.0000000000002747"xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/author"Bai H."xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/author"Wang M."xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/author"Zhang W."xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/author"Zhang J."xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/author"Wu H."xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/author"Yuan F."xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/author"Zheng K."xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/author"Gong J."xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/author"Miao M."xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/name"Transplantation"xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/pages"e188-e197"xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/title"SHMT2 Promotes Liver Regeneration Through Glycine-activated Akt/mTOR Pathway."xsd:string
http://purl.uniprot.org/citations/30964837http://purl.uniprot.org/core/volume"103"xsd:string
http://purl.uniprot.org/citations/30964837http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/30964837
http://purl.uniprot.org/citations/30964837http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/30964837
http://purl.uniprot.org/uniprot/#_Q9CZN7-mappedCitation-30964837http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30964837
http://purl.uniprot.org/uniprot/Q9CZN7http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/30964837